EcoDrugPlus

Ribosomal Protein S24

Ensembl ID : ENSPLAG00000022054
Gene Symbol: RPS24
1 Cross references
486 Possible Orthologues:

Ribosomal Protein S24

Ensembl ID : ENSPLAG00000023600
Gene Symbol: RPS24
3 Cross references
485 Possible Orthologues:

Ribosomal Protein S25

Ensembl ID : ENSPLAG00000010946
Gene Symbol: RPS25
3 Cross references
450 Possible Orthologues:

Ribosomal Protein S26

Ensembl ID : ENSPLAG00000015579
Gene Symbol: RPS26
3 Cross references
405 Possible Orthologues:

Ribosomal Protein S3a

Ensembl ID : ENSPLAG00000015475
Gene Symbol: RPS3A
4 Cross references
359 Possible Orthologues:

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSPLAG00000003887
Gene Symbol: RPS4X
3 Cross references
495 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSPLAG00000009866
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSPLAG00000003759
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSPLAG00000012829
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSPLAG00000010747
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P1

Ensembl ID : ENSPLAG00000013328
Gene Symbol: RPLP1
3 Cross references
382 Possible Orthologues:

Serine/threonine-Protein Kinase Aurora-2-Like

Ensembl ID : ENSPLAG00000012706
Gene Symbol: LOC106965150
3 Cross references
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).